rAAV-hSyn
The hSyn promoter, derived from the human synapsin 1 gene, is a neuron-specific promoter commonly used in recombinant adeno-associated virus (rAAV) systems. Its specificity for neurons makes it a widely used tool for studying and manipulating neural circuits and functions.
Features of rAAV-hSyn
- Neuron-Specific Expression:
- The hSyn promoter drives transgene expression specifically in neurons, ensuring minimal off-target expression in glia or other cell types.
- Broad Compatibility:
- Functional across excitatory and inhibitory neurons in various species, including rodents, non-human primates, and humans.
- High Expression:
- Provides robust and consistent expression in neurons while maintaining cell-type specificity.
- Long-Term Stability:
- Enables sustained transgene expression, suitable for chronic studies.
Applications of rAAV-hSyn
- Neuroscience Research:
- Circuit Mapping: Expression of tracers or fluorescent proteins to study neural connectivity.
- Optogenetics: Delivery of optogenetic tools (e.g., channelrhodopsins, halorhodopsins) for precise neural activation or silencing.
- Calcium Imaging: Use of calcium indicators (e.g., GCaMP) to monitor neuronal activity.
- Gene Therapy:
- Experimental therapies targeting neurons for neurodegenerative diseases (e.g., Parkinson's, Alzheimer's) and other CNS disorders.
- Behavioral Studies:
- Manipulating specific neural circuits to investigate their role in behaviors, such as learning, memory, or motor control.
- CRISPR/Cas9 Genome Editing:
- Delivery of gene-editing components selectively to neurons for targeted gene modification.
- Neurodegenerative Disease Modeling:
- Introduction of disease-related genes or knockdown of neuronal genes to model disorders in vivo.
rAAV-hSyn is a powerful and reliable tool for neuron-specific gene delivery in neuroscience and gene therapy applications. Its broad applicability and strong, stable expression make it a preferred choice for studying and manipulating neural circuits and for developing targeted therapies for CNS disorders.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|